163 related articles for article (PubMed ID: 11534286)
21. [Localized thermotherapy in malignant tumors. Preliminary clinical evaluation].
Pontiggia P; Le Veen H; Ganzetti GL
Recenti Prog Med; 1981 May; 70(5):524-44. PubMed ID: 6273978
[No Abstract] [Full Text] [Related]
22. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
23. [Planning of fractionated methods of lung irradiation using the TDF factor].
Klepper LIa; Makarova GV
Med Tekh; 1996; (6):16-20. PubMed ID: 9053703
[TBL] [Abstract][Full Text] [Related]
24. Sublethal damage repair in two radioresistant human tumor cell lines irradiated as multicellular spheroids.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
Tumour Biol; 1991; 12(4):207-16. PubMed ID: 1871510
[TBL] [Abstract][Full Text] [Related]
25. Time-dependent cell disintegration kinetics in lung tumors after irradiation.
Chvetsov AV; Palta JJ; Nagata Y
Phys Med Biol; 2008 May; 53(9):2413-23. PubMed ID: 18421118
[TBL] [Abstract][Full Text] [Related]
26. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
[TBL] [Abstract][Full Text] [Related]
27. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
28. [Theoretical evaluation of the effectiveness of fractionated irradiation of malignant cells with different radiosensitivities].
Lisin VA
Radiobiologiia; 1984; 24(2):255-7. PubMed ID: 6587433
[TBL] [Abstract][Full Text] [Related]
29. TCP and NTCP: a basic introduction.
Baumann M; Petersen C
Rays; 2005; 30(2):99-104. PubMed ID: 16294901
[TBL] [Abstract][Full Text] [Related]
30. [Approximate methods for calculation of the likelihood of radiation-induced complications. 1. ACLRC method. 2. CERC method].
Klepper LIa
Med Tekh; 2001; (6):12-8. PubMed ID: 11837187
[TBL] [Abstract][Full Text] [Related]
31. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
Toulany M; Dittmann K; Baumann M; Rodemann HP
Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
[TBL] [Abstract][Full Text] [Related]
33. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
Gridley DS; Bonnet RB; Bush DA; Franke C; Cheek GA; Slater JD; Slater JM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):759-66. PubMed ID: 15465192
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy for superior vena caval syndrome due to lung cancer.
Slawson RG; Prempree T; Viravathana T; Kim IS; Scott RM
Md State Med J; 1981 Nov; 30(11):68-70. PubMed ID: 6279975
[No Abstract] [Full Text] [Related]
35. [The radiobiological aspects in the blocking of sensitive structures from the irradiation field].
Dubben HH; Herrmann T
Strahlenther Onkol; 1995 Apr; 171(4):214-7; discussion 218. PubMed ID: 7740409
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
37. [Interactive determination of the parameters of mathematical models in planning radiotherapy of malignant tumors. 3. Method of local adjustment of the parameters of mathematical models (examples of application)].
Klepper LIa
Med Tekh; 2001; (1):27-33. PubMed ID: 11244851
[TBL] [Abstract][Full Text] [Related]
38. Application of carbon-ion beams or gamma-rays on primary tumors does not change the expression profiles of metastatic tumors in an in vivo murine model.
Tamaki T; Iwakawa M; Ohno T; Imadome K; Nakawatari M; Sakai M; Tsujii H; Nakano T; Imai T
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):210-8. PubMed ID: 19362239
[TBL] [Abstract][Full Text] [Related]
39. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
40. Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status.
Oya N; Zölzer F; Werner F; Streffer C
Strahlenther Onkol; 2003 Feb; 179(2):99-106. PubMed ID: 12590320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
